SoundBite Medical Solutions Announces Having Received CE Marking for its SoundBite™ Crossing System Peripheral Gen 2
MONTREAL – December 18, 2018 – SoundBite Medical Solutions Inc. (SBMS) announced today that it has received CE Marking for its SoundBite™ Crossing System Peripheral Gen 2, an improved version of its shockwave-based technology platform that is intended for the treatment of peripheral Chronic Total Occlusions (CTOs).
CE Marking indicates that the product complies with the Essential Requirements of the 93/42/EEC Directive and is authorized to be distributed and commercialized in the European market.
“The award of this CE Mark is another significant milestone for the Company and will allow us to begin our commercial activities with an improved console and guidewire, starting in Europe and later in North America,” said Francis Bellido, President and CEO of SBMS.
About SoundBite Medical Solutions
SoundBite is a privately-held medical device company developing products in the field of vessel preparation for the management and treatment of calcified and occlusive lesions in coronary and peripheral arterial diseases. SoundBite will leverage its shock wave technology platform to clinically and commercially validate its calcium management medical devices with active wires and microcatheters. Peripheral artery disease (PAD) and coronary artery disease (CAD) affect more than 12 million & 16 million people in the US, respectively.
For additional information visit www.soundbitemedical.com
For information on SoundBite Medical Solutions, please contact Mandy Di Lazzaro, Director, Human Resources & Communications (firstname.lastname@example.org) or Francis Bellido, CEO (email@example.com), SoundBite Medical Solutions, 2300 Alfred Nobel, Technoparc St-Laurent, Montreal Québec H4S 2A4
This press release contains forward-looking statements and forward-looking information, or, collectively, forward-looking statements, within the meaning of applicable securities laws, that are based on our management’s belief and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as “may”, “will”, “should”, “could”, “would”, “outlook”, “believe”, “plan”, “envisage”, “anticipate”, “expect” and “estimate” or the negatives of these terms, or variations of them. Forward-looking statements are based upon a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond SoundBite Medical Solutions Inc.’s control that could cause actual results to differ materially from those that are disclosed in or implied by such forward-looking information. The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward looking statements. Forward-looking statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date. We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances.